Follow
Ewa Wunsch
Ewa Wunsch
Pomorski Uniwersytet Medyczny
Verified email at pum.edu.pl
Title
Cited by
Cited by
Year
Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis
E Wunsch, J Trottier, M Milkiewicz, J Raszeja‐Wyszomirska, ...
Hepatology 60 (3), 931-940, 2014
1262014
Expression of hepatic fibroblast growth factor 19 is enhanced in primary biliary cirrhosis and correlates with severity of the disease
E Wunsch, M Milkiewicz, U Wasik, J Trottier, A Kempińska-Podhorodecka, ...
Scientific reports 5 (1), 13462, 2015
1032015
Enhanced liver fibrosis test predicts transplant‐free survival in primary sclerosing cholangitis, a multi‐centre study
EMG De Vries, M Färkkilä, P Milkiewicz, JR Hov, B Eksteen, D Thorburn, ...
Liver International 37 (10), 1554-1561, 2017
812017
Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseases
E Wunsch, M Krawczyk, M Milkiewicz, J Trottier, O Barbier, MF Neurath, ...
Scientific reports 6 (1), 30847, 2016
582016
Minimal hepatic encephalopathy does not impair health‐related quality of life in patients with cirrhosis: a prospective study
E Wunsch, B Szymanik, M Post, W Marlicz, M Mydłowska, P Milkiewicz
Liver International 31 (7), 980-984, 2011
542011
Assessment of health related quality of life in polish patients with primary biliary cirrhosis
J Raszeja-Wyszomirska, E Wunsch, M Krawczyk, EI Rigopoulou, ...
Clinics and research in hepatology and gastroenterology 40 (4), 471-479, 2016
522016
Esophageal duplication cysts: endosonographic findings in asymptomatic patients
A Wiechowska-Kozłowska, E Wunsch, M Majewski, P Milkiewicz
World journal of gastroenterology: WJG 18 (11), 1270, 2012
472012
Autoimmune hepatitis exerts a profound, negative effect on health‐related quality of life: a prospective, single‐centre study
MK Janik, E Wunsch, J Raszeja‐Wyszomirska, M Moskwa, B Kruk, ...
Liver International 39 (1), 215-221, 2019
462019
Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open …
E Wunsch, J Raszeja-Wyszomirska, O Barbier, M Milkiewicz, M Krawczyk, ...
J Gastrointestin Liver Dis 27 (3), 273-279, 2018
462018
The effect of short term treatment with probiotic VSL# 3 on various clinical and biochemical parameters in patients with liver cirrhosis
W Marlicz, E Wunsch, M Mydlowska, M Milkiewicz, K Serwin, M Mularczyk, ...
J Physiol Pharmacol 67 (6), 867-877, 2016
442016
Vitamin D receptor polymorphisms predispose to primary biliary cirrhosis and severity of the disease in polish population
A Kempińska-Podhorecka, E Wunsch, T Jarowicz, ...
Gastroenterology Research and Practice 2012 (1), 408723, 2012
432012
Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study
E Wunsch, D Koziarska, K Kotarska, P Nowacki, P Milkiewicz
Liver international 33 (9), 1332-1340, 2013
412013
Factors affecting health‐related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre …
K Kotarska, E Wunsch, A Kempińska-Podhorodecka, ...
Journal of immunology research 2014 (1), 738297, 2014
402014
Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study
D Koziarska, E Wunsch, M Milkiewicz, M Wójcicki, P Nowacki, ...
BMC gastroenterology 13, 1-7, 2013
392013
Impaired hepatic adaptation to chronic cholestasis induced by primary sclerosing cholangitis
M Milkiewicz, M Klak, A Kempinska-Podhorodecka, ...
Scientific Reports 6 (1), 39573, 2016
362016
Prospective evaluation of PBC‐specific health‐related quality of life questionnaires in patients with primary sclerosing cholangitis
J Raszeja‐Wyszomirska, E Wunsch, M Krawczyk, EI Rigopoulou, ...
Liver International 35 (6), 1764-1771, 2015
362015
Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and …
E Wunsch, GL Norman, M Milkiewicz, M Krawczyk, C Bentow, Z Shums, ...
Alimentary Pharmacology & Therapeutics 53 (2), 302-313, 2021
352021
Plasmapheresis exerts a long‐lasting antipruritic effect in severe cholestatic itch
M Krawczyk, R Liebe, M Wasilewicz, E Wunsch, J Raszeja‐Wyszomirska, ...
Liver International 37 (5), 743-747, 2017
352017
Impact on follow‐up strategies in patients with primary sclerosing cholangitis
A Bergquist, TJ Weismüller, C Levy, C Rupp, D Joshi, JS Nayagam, ...
Liver international 43 (1), 127-138, 2023
322023
The prevalence of anti-hexokinase-1 and anti-kelch-like 12 peptide antibodies in patients with primary biliary cholangitis is similar in Europe and North America: a large …
GL Norman, A Reig, O Viñas, M Mahler, E Wunsch, P Milkiewicz, ...
Frontiers in immunology 10, 662, 2019
292019
The system can't perform the operation now. Try again later.
Articles 1–20